8-K · Filed 15 Oct 2026 · Biotech
CRON · Cronos Group Inc.
Cronos completed acquisition of CanAdelaar, Europe's largest adult-use cannabis operator in Dutch pilot program, for €57.5M base plus EBITDA earnouts. Establishes European platform with #1 market share but faces pending regulatory and environmental risks.
The filings read more positively.
Progress is running ahead of attention.
8-K · Items 1.01, 2.02, 8.01 — Material agreement
Recognition: Balanced 47 → Watch 42 · Value: Balanced 50 → Balanced 46 · Gap Medium · 17 → Very high · 67
Market attention has faded.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-K · Items 1.01, 2.03 — Material agreement
Gap Medium · 19 → Very high · 72
Progress is running ahead of attention.
The price trend strengthened.
8-K · Items 1.01, 2.03 — Material agreement
Gap Very high · 48 → Low · 0
The gap closed as the filings read less positively.
8-K · Items 1.01, 3.02 — Material agreement
News flow: Balanced 51 → Balanced 55 · Gap Medium · 11 → Very high · 54
The filings read more positively.
Progress is running ahead of attention.
Expected dates come from each company's filing history. They are not forecasts, and companies move them.
Full calendar →AIR Discovery™ studies the filings of ~1,800 under-followed US companies — and explains every score it gives.
AIR explains how it reads the filings — and publishes what it said, every month, without changing it afterwards.
Tested on data the system had never seen.
Companies AIR surfaces gain measurably more market recognition within six months than closely matched peers. Read the research →
Which filing. Which decision. Which change. Each one linked to the original public record, so you can check our work — and disagree with it.
8-K filings, quarterly reports, regulatory decisions — for ~1,800 companies, every day. The reading no one has time for.
How much is the market actually watching? The Discovery Gap shows where documented progress is outpacing attention.
Five perspectives behind every AIR Score™, in plain words, with sources. When data is missing, it says so.
Why AIR
AIR scores ~1,800 US-listed companies worth roughly $500 million to $15 billion — the range where a business can change materially before most people notice. It measures the gap between how a company is doing and how much attention it is getting, and surfaces the ones where that gap is widest.
AIR reads three public sources: SEC EDGAR filings, FDA drug approvals and end-of-day prices. The five perspectives behind an AIR Score — Fundamentals, Value, News flow, Momentum, Safety — are shown on every company page with what each one reads. Every score is recomputed nightly by fixed, versioned formulas; a language model writes the explanations and helps classify whether each 8-K is positive or negative.
On the last day of each month AIR publishes a point-in-time snapshot of what it scored and where. Snapshots are never restated. What AIR said on 31 August is what you see today, including the calls it got wrong.
Free. No ads. No account needed to look around.
Everyone covers the giants. In between sit ~1,800 mid-sized US companies where real change can sit in public filings for months. We look — daily.
No passwords. We email you a sign-in link and a 6-digit code — use whichever is easier.
By continuing you agree to the Terms and acknowledge the Privacy Policy. AIR provides research, not investment advice.
Research, not tips. AIR provides descriptive measures based on public information — not investment advice or recommendations. Investing involves risk, including loss of principal.